ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991

NTP Board Gives Concept Approvals

December 4, 1981

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993